Skip to main content
Donate

About FAST

Global Science Summit & Gala

5 photos of the summit and gala

The 2026 FAST Global Science Summit & Gala

Our biggest event of the year will be held at the Hyatt Regency Orlando November 5-7, 2026.

  • Thursday, November 5:

  • Friday, November 6:

    • All Day: Global Science Summit

  • Saturday, November 7:

    • Morning: Global Science Summit

    • Evening: FAST Gala, an 18+ formal celebration

Key Registration Dates

  • Aug 3: In-Person and virtual registration opens

  • Aug 31: Deadline for early bird registration and have your loved one featured in our Gala video

  • Oct 14: Hotel block closes

  • Oct 27: In-Person registration closes

International Guests

If you live outside of the United States and will need a visa to travel to the US, please consider applying now. If you would like FAST to write you a letter of invitation for you to enclose with your visa application, we are happy to do so. To request a letter of invitation, please email events@cureangelman.org and provide the full names of the people in your family who will attend.

Scholarships for Parents & Professionals

The application window for the Parent & Caregiver Global Science Summit & Gala Scholarships and Professional Travel Award is now closed.

  • June 1: Applications open

  • June 16: Applications closed

  • June 26: Winners notified via email

To check the status of your application, please email events@cureangelman.org

Frequently Asked Questions

If you've never attended this event, please check out the FAQs. If you have a question that is not listed, please email events@cureangelman.org

Sponsors and Exhibitors

If your business or organization is interested in sponsoring or exhibiting at the event, please email events@cureangelman.org.

This is the biggest science and drug development event devoted to Angelman syndrome.

Learn more about the event.

The Global Science Summit is preceded by the Translational Research Symposium and Angelman Syndrome Biomarker and Outcome Measure Consortium (A-BOM) meeting which will be on November 5, 2026 in Orlando, FL. This is an event for the research community by invite only. If you are interested in attending, email events@cureangelman.org.

TRS-ABOM

What is A-BOM?

Registration sign at TRS-ABOM in 2024.

2025 Global Science Summit & Gala Recap

FAST Angelman Syndrome News

Nonprofit Leader and Attorney Alice Rodd O’Rourke, JD Joins FAST Board of Directors

Spring Advocacy Update: Educating, Advocating, and Building Momentum

FAST Brings Angelman Syndrome Community Perspective to FDA Rare Disease Roundtable

A Sister-Led Sip & Shop Turns Jewelry Into Support for FAST

Update on Rugonersen Development and Planned Phase 3 Study  (BEACON)  

Non-viral delivery gene editing takes an important step forward for Angelman syndrome

FAST LATAM Brings Families and Research Together in Mexico City

FAST at ASGCT 2026

Using Vocalization Testing to Improve Detection of Treatment Effects in Angelman Syndrome Models

FAST's Action Council member, Joe D'Orazio, shares his story with CNBC Cures

2026 Congressional Advocacy Day: Recap and Successes

Career Development Awards Expand the Next Wave of Angelman Syndrome Research

Important update on alogabat, an investigational therapy in development for Angelman syndrome

FAST Poland hosts second nationwide conference, "From Diagnosis to Therapy."

Measuring Communication in Angelman Syndrome to Support Better Trials

Celebrating Dr. David Segal: A Leader in Science and a Champion for Angelman Syndrome Research

International Angelman Day 2026: What Our Community Made Possible

FAST Leaders to Speak at the CNBC Cures Summit on Patient- and Family-Led Advocacy

AS Natural History Study Celebrates 20 Years!

International Angelman Day Bash: Starting Small, Showing Up Big

Nonprofit Leader and Attorney Alice Rodd O’Rourke, JD Joins FAST Board of Directors

Spring Advocacy Update: Educating, Advocating, and Building Momentum

FAST Brings Angelman Syndrome Community Perspective to FDA Rare Disease Roundtable

A Sister-Led Sip & Shop Turns Jewelry Into Support for FAST

Update on Rugonersen Development and Planned Phase 3 Study  (BEACON)  

Non-viral delivery gene editing takes an important step forward for Angelman syndrome

FAST LATAM Brings Families and Research Together in Mexico City

FAST at ASGCT 2026

Using Vocalization Testing to Improve Detection of Treatment Effects in Angelman Syndrome Models

FAST's Action Council member, Joe D'Orazio, shares his story with CNBC Cures

2026 Congressional Advocacy Day: Recap and Successes

Career Development Awards Expand the Next Wave of Angelman Syndrome Research

Important update on alogabat, an investigational therapy in development for Angelman syndrome

FAST Poland hosts second nationwide conference, "From Diagnosis to Therapy."

Measuring Communication in Angelman Syndrome to Support Better Trials

Celebrating Dr. David Segal: A Leader in Science and a Champion for Angelman Syndrome Research

International Angelman Day 2026: What Our Community Made Possible

FAST Leaders to Speak at the CNBC Cures Summit on Patient- and Family-Led Advocacy

AS Natural History Study Celebrates 20 Years!

International Angelman Day Bash: Starting Small, Showing Up Big

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.